ChemFeeds Site Navigation:
Journal Selection:
Search:

99) TBI-Induced IL12 Augments Tc17 Activity (Clinical Cancer Research) Sunday May 31st 2015


100) Targeting Syk in Waldenstrom Macroglobulinemia (Clinical Cancer Research) Sunday May 31st 2015


101) PIK3CA Mutations Predictive of Bad Response in Cervix Cancer (Clinical Cancer Research) Sunday May 31st 2015


102) Optimal Patient Selection for Trastuzumab Treatment in AGC (Clinical Cancer Research) Sunday May 31st 2015


103) Rigidity Analysis Affects Treatment of Skeletal Metastasis (Clinical Cancer Research) Sunday May 31st 2015


104) Diffusion-Weighted MRI for Lymphoma Restaging (Clinical Cancer Research) Sunday May 31st 2015


105) NRF2 Pathway and Chemotherapy in Lung Squamous Cell Carcinoma (Clinical Cancer Research) Sunday May 31st 2015


106) Multiparameter Characterization of Circulating Tumor Cells (Clinical Cancer Research) Sunday May 31st 2015


107) Phase I Trial of ADI-PEG 20 Plus Docetaxel (Clinical Cancer Research) Sunday May 31st 2015


108) Angiotensin System Inhibitors in Renal Cell Carcinoma (Clinical Cancer Research) Sunday May 31st 2015


109) MEHD7945A in Refractory/Recurrent Epithelial Tumors (Clinical Cancer Research) Sunday May 31st 2015


110) Exposure-Response of Rilotumumab in Gastric Cancer Patients (Clinical Cancer Research) Sunday May 31st 2015


111) Eribulin: A Unique Microtubule-Targeting Agent (Clinical Cancer Research) Sunday May 31st 2015


112) Targeting Cellular Energy Metabolism in Cancer (Clinical Cancer Research) Sunday May 31st 2015


113) FDA Approval of Ceritinib for ALK-Positive NSCLC (Clinical Cancer Research) Sunday May 31st 2015


114) Combinatorial Therapy for Melanoma (Clinical Cancer Research) Sunday May 31st 2015


115) Circulating Tumor Cell-Based Assay in Breast Cancer (Clinical Cancer Research) Sunday May 31st 2015


116) RB and Resected Lung Adenocarcinoma (Clinical Cancer Research) Sunday May 31st 2015


117) Determining a PK/PD Relationship for Sunitinib: A Look Back (Clinical Cancer Research) Sunday May 31st 2015


118) Correction: Ceritinib for the Treatment of Late-Stage (Metastatic) Non-Small Cell Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


119) Role of miRNA-137/197 in Myeloma (Clinical Cancer Research) Friday May 15th 2015


120) GLI Is a Negative Prognostic Marker in AML (Clinical Cancer Research) Friday May 15th 2015


121) Crizotinib Resistance in ROS1-Rearranged NSCLC (Clinical Cancer Research) Friday May 15th 2015


122) Molecular Subtyping of DLBCL Samples with NanoString (Clinical Cancer Research) Friday May 15th 2015


123) HHLA Is the Newest Immune Checkpoint in Human Cancers (Clinical Cancer Research) Friday May 15th 2015


124) B-ALLs Are Sensitive to an HDAC1/HDAC2 Inhibitor (Clinical Cancer Research) Friday May 15th 2015


125) Intracellular Delivery of GO-203 in Novel Tetrablock Nanoparticles (Clinical Cancer Research) Friday May 15th 2015


126) CD47 Targets Pancreatic Cancer Stem Cells (Clinical Cancer Research) Friday May 15th 2015


127) AR Gene Aberrations in Circulating Cell-Free DNA (Clinical Cancer Research) Friday May 15th 2015


128) Targeted T-cell Therapy in Metastatic Breast Cancer Patients (Clinical Cancer Research) Friday May 15th 2015


129) Clinical and Preclinical Assessment of TKI JNJ-38877605 (Clinical Cancer Research) Friday May 15th 2015


130) Nilotinib in Previously Treated KIT-Altered Melanoma (Clinical Cancer Research) Friday May 15th 2015


131) NFAT-IL12 in TIL Trial (Clinical Cancer Research) Friday May 15th 2015


132) MAGE-A4 TCR-Transduced T-cell Transfer for Esophageal Cancer (Clinical Cancer Research) Friday May 15th 2015


133) Accelerating the Delivery of Patient-Centered, High-Quality Cancer Care (Clinical Cancer Research) Friday May 15th 2015


134) Immune Checkpoint Modulation for Non-Small Cell Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


135) Recent Progress in SCLC May Lead to Improved Outcomes (Clinical Cancer Research) Friday May 15th 2015


136) Squamous Cell Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


137) ALK in Cancer (Clinical Cancer Research) Friday May 15th 2015


138) EGFR as Paradigm of an Oncogene-Driven Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


139) Integrating Lung Cancer Genomics and Therapeutics (Clinical Cancer Research) Friday May 15th 2015


140) Quit Early, Quit Often (Clinical Cancer Research) Friday May 15th 2015


141) Inducible Drug Glucuronidation (Clinical Cancer Research) Friday May 15th 2015


142) Molecular Classification of Diffuse Large B-cell Lymphoma (Clinical Cancer Research) Friday May 15th 2015


143) HHLA2: A New Target for Cancer Immunotherapy (Clinical Cancer Research) Friday May 15th 2015


144) Vorinostat: Gateway to Epigenetic Therapy (Clinical Cancer Research) Friday May 15th 2015


145) Expanding the Epigenetic Portfolio (Clinical Cancer Research) Friday May 15th 2015


146) Correction: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors (Clinical Cancer Research) Thursday April 30th 2015


147) Correction: Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer (Clinical Cancer Research) Thursday April 30th 2015


148) Retraction: Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression (Clinical Cancer Research) Thursday April 30th 2015


149) RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer--Response (Clinical Cancer Research) Thursday April 30th 2015


150) RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer--Letter (Clinical Cancer Research) Thursday April 30th 2015


151) MiHA Identification by Reverse Immunology (Clinical Cancer Research) Thursday April 30th 2015


152) ITK, a Therapeutic Target in Melanoma (Clinical Cancer Research) Thursday April 30th 2015


153) EGFR Mutations and Resistance to Cetuximab (Clinical Cancer Research) Thursday April 30th 2015


154) Impact of Clone Size on FISH in Myeloma (Clinical Cancer Research) Thursday April 30th 2015


155) Role of PLEKHA5 in Melanoma Brain Metastasis (Clinical Cancer Research) Thursday April 30th 2015


156) Inhibition of Angiogenesis by Zoledronic Acid (Clinical Cancer Research) Thursday April 30th 2015


157) Targeted Therapy in CLL (Clinical Cancer Research) Thursday April 30th 2015


158) Chemotherapy Contributes to Drug Resistance (Clinical Cancer Research) Thursday April 30th 2015


159) Pralatrexate and Romidepsin in Preclinical T-cell Lymphoma (Clinical Cancer Research) Thursday April 30th 2015


160) Antitumor Effect of Notch2/3 Antagonist (Tarextumab) (Clinical Cancer Research) Thursday April 30th 2015


161) "Don't Eat Me" aAPC for Enhanced In Vivo Function (Clinical Cancer Research) Thursday April 30th 2015


162) PTEN Status and Clinical Outcome in Breast Cancer (Clinical Cancer Research) Thursday April 30th 2015


163) DIRECTOR Trial for Recurrent Glioblastoma (Clinical Cancer Research) Thursday April 30th 2015


164) Genomic Complexity, Gene Mutations, and Outcomes in AML (Clinical Cancer Research) Thursday April 30th 2015


165) MIR27A Polymorphisms and Fluoropyrimidine Toxicity (Clinical Cancer Research) Thursday April 30th 2015


166) The Individualized Molecular Pancreatic Cancer Therapy Trial (Clinical Cancer Research) Thursday April 30th 2015


167) Impact of cGVHD on Late Relapse and Survival (Clinical Cancer Research) Thursday April 30th 2015


168) Genomics of HPV-Associated Cancers (Clinical Cancer Research) Thursday April 30th 2015


169) State of the Art: MRD Testing for Myeloma (Clinical Cancer Research) Thursday April 30th 2015


170) Improving Radiotherapy via Modification of Oxygenation (Clinical Cancer Research) Thursday April 30th 2015


171) Targeting NRG1 Fusions (Clinical Cancer Research) Thursday April 30th 2015


172) Exploiting the New Biology of Glioblastoma (Clinical Cancer Research) Thursday April 30th 2015


173) Chronic GVHD and Leukemia Relapse (Clinical Cancer Research) Thursday April 30th 2015


174) Role of PLEKHA5 in CNS Homing (Clinical Cancer Research) Thursday April 30th 2015


175) Nab-Paclitaxel: How Far Science Has Come (Clinical Cancer Research) Thursday April 30th 2015


176) Chemoresistance in Fanconi Anemia Head and Neck Cancers (Clinical Cancer Research) Wednesday April 15th 2015


177) Implications for Tumor Classifications and Targeted Therapies (Clinical Cancer Research) Wednesday April 15th 2015


178) Very Long-term Survival in Pancreatic Cancer (Clinical Cancer Research) Wednesday April 15th 2015


179) MEK1 Mutations in Lung Carcinoma (Clinical Cancer Research) Wednesday April 15th 2015


180) S1P Inhibition as a New Treatment for RCC (Clinical Cancer Research) Wednesday April 15th 2015


181) Efficacy of MK-1775 in PDX Models of GBM (Clinical Cancer Research) Wednesday April 15th 2015


182) Gene Expression-Based Risk Stratification of Neuroblastoma (Clinical Cancer Research) Wednesday April 15th 2015


183) Bevacizumab in NSCLC Patients with Asymptomatic Brain Metastases (Clinical Cancer Research) Wednesday April 15th 2015


184) First-in-Human Study of PF-05212384 in Advanced Cancers (Clinical Cancer Research) Wednesday April 15th 2015


185) Impact of Coffee on Breast Cancer (Clinical Cancer Research) Wednesday April 15th 2015


186) Infections and PI3K-AKT-mTOR Inhibitors (Clinical Cancer Research) Wednesday April 15th 2015


187) Biologic Activity of Everolimus in Resectable Lung Cancer (Clinical Cancer Research) Wednesday April 15th 2015


188) Bevacizumab Preconditioned Regimen in Brain Metastases (Clinical Cancer Research) Wednesday April 15th 2015


189) JNJ-40346527 for Relapsed or Refractory Hodgkin Lymphoma (Clinical Cancer Research) Wednesday April 15th 2015


190) Lenalidomide-Rituximab for Rituximab-Resistant Lymphoma (Clinical Cancer Research) Wednesday April 15th 2015


191) Ras and Cancer Metabolism (Clinical Cancer Research) Wednesday April 15th 2015


192) Targeting RAS Membrane Interactions (Clinical Cancer Research) Wednesday April 15th 2015


193) Direct Attack on RAS (Clinical Cancer Research) Wednesday April 15th 2015


194) RAS Synthetic Lethal Screens Revisited (Clinical Cancer Research) Wednesday April 15th 2015


195) KRAS as a Therapeutic Target (Clinical Cancer Research) Wednesday April 15th 2015


196) Targeting RAS: The Elusive Prize (Clinical Cancer Research) Wednesday April 15th 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()